FlowCardia, Inc., a worldwide leader in the development of endovascular devices for the treatment of chronic total occlusions (CTOs), today announced the appointment of Chris Barys to the position of Chief Operating Officer.
FlowCardia, Inc., a worldwide leader in the development of endovascular devices for the treatment of chronic total occlusions (CTOs), today announced the appointment of Chris Barys to the position of Chief Operating Officer.